Related Experiment Videos
Recurrence of de novo graft membranous glomerulonephritis
Abstract:
Graft membranous nephropathy (MN) appears mainly de novo or, less frequently, develops in patients whose original disease was MN. The rarity of the latter occurrence contrasts with the frequency of MN as the original disease: the existence of renal recurrence may thus be questioned. We report a patient with terminal renal failure due to focal glomerulosclerosis; typical MN developed de novo in the first and recurred in the third graft. This observation establishes that recurrence of MN is a real phenomenon and demonstrates that the factor(s) determining recurrence may appear only after transplantation. Neither HBs nor antilymphocyte serum antigens were found along the basement membrane. The late onset of proteinuria after the third demonstrates that the delayed appearance of clinical signs of glomerular disease does not rule out the occurrence of MN.
Insights
Recurrence of membranous nephropathy (MN) after kidney transplantation is a real phenomenon. This case highlights that factors causing MN may emerge post-transplant, leading to delayed clinical signs.
Area of Science:
- Nephrology
- Transplantation Immunology
- Glomerular Diseases
Background:
- Membranous nephropathy (MN) is a leading cause of nephrotic syndrome in adults.
- MN can occur de novo after kidney transplantation or recur in patients with a history of the disease.
- The recurrence of MN in patients with prior MN is less understood than de novo occurrence.
Observation:
- A patient with end-stage renal failure due to focal glomerulosclerosis received multiple kidney transplants.
- Membranous nephropathy developed de novo in the first graft and recurred in the third graft.
- No specific antigens (HBs, antilymphocyte serum) were identified in the glomerular basement membrane.
Findings:
- This case confirms that membranous nephropathy recurrence is a genuine clinical event.
- The study suggests that factors triggering MN recurrence may develop after the transplantation procedure.
- Late-onset proteinuria in the third graft indicates that clinical manifestation of glomerular disease can be delayed.
Implications:
- The findings challenge the notion that MN recurrence is rare in patients with a history of the disease.
- Understanding the post-transplant factors is crucial for managing MN recurrence.
- Delayed clinical presentation does not exclude the development of post-transplant glomerular diseases like MN.